Page last updated: 2024-08-26

yttrium radioisotopes and ER-Negative PR-Negative HER2-Negative Breast Cancer

yttrium radioisotopes has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanaoka, H; Katsumata, N; Tsushima, Y; Yamaguchi, A; Yudistiro, R	1

Other Studies

1 other study(ies) available for yttrium radioisotopes and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase. Molecular pharmaceutics, 2018, 06-04, Volume: 15, Issue:6 Topics: Animals; Avidin; Bevacizumab; Biotin; Cell Line, Tumor; Female; Humans; Immunoconjugates; Metabolic Clearance Rate; Mice, Inbred BALB C; Mice, Nude; Radioimmunotherapy; Tissue Distribution; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays; Yttrium Radioisotopes	2018

Article

Year

Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase.

Molecular pharmaceutics, 2018, 06-04, Volume: 15, Issue:6

Topics: Animals; Avidin; Bevacizumab; Biotin; Cell Line, Tumor; Female; Humans; Immunoconjugates; Metabolic Clearance Rate; Mice, Inbred BALB C; Mice, Nude; Radioimmunotherapy; Tissue Distribution; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays; Yttrium Radioisotopes

2018